Suppr超能文献

阿尔茨海默病β-淀粉样蛋白前体/蛋白酶nexin-II在人神经胶质瘤细胞的反式高尔基体分泌区室中被分泌酶切割。

The Alzheimer beta-amyloid protein precursor/protease nexin-II is cleaved by secretase in a trans-Golgi secretory compartment in human neuroglioma cells.

作者信息

Kuentzel S L, Ali S M, Altman R A, Greenberg B D, Raub T J

机构信息

Upjohn Laboratories, Upjohn Company, Kalamazoo, MI 49001.

出版信息

Biochem J. 1993 Oct 15;295 ( Pt 2)(Pt 2):367-78. doi: 10.1042/bj2950367.

Abstract

Alzheimer beta-amyloid protein precursor (beta APP) is expressed endogenously and abundantly by human neuroglioma (H4) cells. Its secretory processing has been shown to involve discrete proteolysis within the beta A4 region, thus preventing beta-amyloid formation, by an enzyme which has been referred to as 'beta APP secretase'. This cleavage results in secretion of a soluble N-terminal 135 kDa protein and retention of an integral membrane C-terminal fragment within the cell. The membrane-associated C-terminal fragment is sorted to lysosomes where it undergoes limited degradation. We show here that most newly synthesized beta APP is degraded via a non-lysosomal pathway before maturation in H4 cells, and most mature beta APP is processed predominantly by the so-called secretase. The rapid kinetics of appearance/disappearance of a cleaved 135 kDa protein within a microsomal fraction and the slow accumulation of this form in the extracellular medium indicated that secretase cleaves beta APP in an intracellular compartment. Low-temperature block (20 degrees C) was used to demonstrate that beta APP is cleaved within a late Golgi compartment after sulphation which occurs in the trans-Golgi network (TGN). This is consistent with (1) the immunolocalization of most of the beta APP within a Golgi compartment that reacts with wheat germ agglutinin, (2) the fact that less than 1.5% of the total mature full-length beta APP is present at the plasma membrane and (3) subcellular fractionation studies which showed that the mature full-length and intracellular cleaved beta APPs co-sediment with a membrane fraction that is slightly more dense than the plasma membrane. This study provides evidence that most of the beta APP secretase in H4 cells is intracellular, and confirms that the resulting C-terminal fragment is delivered to lysosomes immediately after cleavage. These results are discussed with regard to the possibility that mature full-length beta APP escapes secretase cleavage and is delivered directly from the TGN to the lysosome without passing through the plasma membrane. Either pathway will result in the generation of amyloidogenic fragments.

摘要

阿尔茨海默病β-淀粉样蛋白前体(β-APP)在人神经胶质瘤(H4)细胞中大量内源性表达。其分泌过程已表明涉及β-A4区域内的离散蛋白水解,从而通过一种被称为“β-APP分泌酶”的酶阻止β-淀粉样蛋白的形成。这种切割导致分泌一种可溶性的N端135 kDa蛋白,并使一个完整的膜结合C端片段保留在细胞内。膜相关的C端片段被分选到溶酶体中,在那里它会经历有限的降解。我们在此表明,在H4细胞中,大多数新合成的β-APP在成熟之前通过非溶酶体途径降解,而大多数成熟的β-APP主要由所谓的分泌酶加工。微粒体部分中切割后的135 kDa蛋白出现/消失的快速动力学以及这种形式在细胞外培养基中的缓慢积累表明,分泌酶在细胞内区室中切割β-APP。利用低温阻断(20℃)来证明β-APP在反式高尔基体网络(TGN)中发生硫酸化后的晚期高尔基体区室中被切割。这与以下几点一致:(1)大多数β-APP在与麦胚凝集素反应的高尔基体区室中的免疫定位;(2)成熟全长β-APP总量中不到1.5%存在于质膜上这一事实;(3)亚细胞分级分离研究表明,成熟的全长和细胞内切割的β-APP与一个比质膜稍致密的膜部分共沉降。这项研究提供了证据,表明H4细胞中的大多数β-APP分泌酶是细胞内的,并证实切割后产生的C端片段会立即被递送至溶酶体。针对成熟全长β-APP逃避分泌酶切割并直接从TGN传递至溶酶体而不经过质膜的可能性,对这些结果进行了讨论。这两种途径都会导致产生淀粉样蛋白生成片段。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59cb/1134891/bf82985c0910/biochemj00101-0050-a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验